ARDT
Ardent Health Partners, LLCNYSEHealthcare$8.66-0.12%ClosedMarket Cap: $1.24B
As of 2026-04-06
Valuation
P/E (TTM)
9.13
PEG
—
P/B
0.75
P/S
0.20
EV/EBITDA
5.65
DCF Value
$85.49
FCF Yield
19.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
97.5%
Operating Margin
8.9%
Net Margin
2.1%
ROE
10.1%
ROA
2.6%
ROIC
10.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.61B | 165.5% | $104.8M | $45.0M | $0.32 | — |
| FY 2025 | $6.32B | 97.5% | $325.6M | $135.8M | $0.96 | — |
| Q3 2025 | $1.58B | 57.1% | $254.3M | $-23.5M | $-0.17 | — |
| Q2 2025 | $1.65B | 83.6% | $137.3M | $73.0M | $0.52 | — |
| Q1 2025 | $1.50B | 82.7% | $67.1M | $41.4M | $0.29 | — |
| Q4 2024 | $1.61B | 59.3% | $336.8M | $114.2M | $0.86 | — |
| FY 2024 | $5.97B | 82.7% | $405.8M | $210.3M | $1.58 | — |
| Q3 2024 | $1.45B | 82.6% | $70.4M | $26.3M | $0.19 | — |
| Q2 2024 | $1.47B | 82.4% | $-157.4M | $42.8M | $0.30 | — |
| Q1 2024 | $1.44B | 82.1% | $75.8M | $27.0M | $0.19 | — |
| Q4 2023 | $1.35B | 55.6% | $171.9M | $-4.2M | $-0.05 | — |
| FY 2023 | $5.41B | 97.4% | $229.5M | $50.3M | $0.35 | — |